Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
Lehtisalo M, Tarkiainen EK, Neuvonen M, Holmberg M, Kiiski JI, Lapatto-Reiniluoto O, Filppula AM, Kurkela M, Backman JT, Niemi M.
Lehtisalo M, et al. Among authors: backman jt.
Clin Pharmacol Ther. 2024 Jan;115(1):71-79. doi: 10.1002/cpt.3067. Epub 2023 Oct 20.
Clin Pharmacol Ther. 2024.
PMID: 37786998
Clinical Trial.